Clinical Trial Update: A Crossover Study to Compare RAYOS to IR Prednisone to Improve Fatigue and Morning Symptoms for SLE [Phase 4]

View source ↗

Summary

A Phase 4 crossover trial comparing RAYOS to immediate-release prednisone in systemic lupus erythematosus to assess fatigue and morning symptoms has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Erythematosus
• Systemic Lupus Erythematosus

Drugs mentioned

• Prednisone Immediate-Release (prednisone)
• RAYOS (prednisone)

Snippet

Sponsor: Ampel BioSolutions, LLC | Conditions: Lupus Erythematosus, Systemic, Lupus Erythematosus | Phase 4 | Status: COMPLETED